Hepatitis Be Included In Universal Immunisation Programme (UIP)

India is reassessing vaccine priorities under the Universal Immunisation Programme (UIP), especially as the government considers adding the Typhoid Conjugate Vaccine (TCV).

About Hepatitis A

  • A viral infection triggered by the Hepatitis A Virus (HAV), spreading mainly through contaminated food, water, or close contact with infected individuals.
  • Produces acute liver inflammation, leading to jaundice, fever, fatigue, vomiting, and abdominal discomfort.
  • No antiviral cure exists; the disease usually resolves on its own within six months, requiring only supportive care.
  • Offers 90–95% protection, provides immunity for 15–20 years or often lifelong, and prevents symptomatic disease.
  • Better sanitation has reduced childhood exposure, but this has pushed infections into adulthood—where disease severity is significantly higher.
Typhoid Conjugate Vaccine TCV

What Is the Universal Immunisation Programme (UIP)?

  • 1985; later integrated with the Child Survival and Safe Motherhood Programme (1992) and the National Rural Health Mission (2005).
  • Coverage: Supplies free vaccines against 12 diseases—nine across India (DPT, Polio, Measles, Rubella, TB, Hepatitis B, Hib) and three in specific states (Rotavirus, JE, Pneumococcal).
  • Contribution: Crucial in polio eradication, reducing measles mortality, and improving overall child survival.

Why Hepatitis A Merits Inclusion in UIP

  • Higher Severity in Adults: Earlier, most Indians were naturally exposed in childhood, but falling transmission has led to rising adult infections, which are far more likely to cause acute liver failure.
  • Increasing Outbreaks: States such as Kerala, Maharashtra, Delhi, and Uttar Pradesh have witnessed repeated clusters, indicating a growing public-health risk.
  • Declining Immunity Levels: Urban seroprevalence has dropped from about 90% to below 60%, leaving millions vulnerable.
  • Availability of an Affordable Indian Vaccine: The indigenous Biovac-A is safe, low-cost, and requires only one dose, making national rollout feasible.
  • No Risk of Antimicrobial Resistance: As a viral disease treated without antibiotics, Hepatitis A avoids the risk of drug resistance—a major concern with other infections.

HEPATITIS

  • Hepatitis refers to liver inflammation caused by viruses, alcohol, drugs, or autoimmune conditions.
  • Viral forms:
    • Hepatitis A: Fecal–oral; acute; vaccine available.
    • Hepatitis B: Blood/body fluids; chronic potential; vaccine available.
    • Hepatitis C: Blood transmission; often chronic; no vaccine.
    • Hepatitis E: Fecal–oral; usually acute.

This topic is available in detail on our main website.

👉 Read Daily Current Affairs – 15th October 2025

Leave a Reply

Your email address will not be published. Required fields are marked *